-
EMA’s response to monkeypox
EMA’s response to monkeypox
-
EMA’s response to monkeypox
EMA’s response to monkeypox
Declaration of public health emergency triggers a series of new actions for a coordinated response
-
Towards better prevention of medicine shortages
Towards better prevention of medicine shortages
-
Towards better prevention of medicine shortages
Towards better prevention of medicine shortages
EMA published a guidance for patients’ and healthcare professionals’ organisations with good practices to support them in preventing and managing shortages of human medicines
-
EMA and ECDC update on COVID-19 booster doses
EMA and ECDC update on COVID-19 booster doses
-
EMA and ECDC update on COVID-19 booster doses
EMA and ECDC update on COVID-19 booster doses
The two EU agencies recommended considering second boosters of mRNA vaccines in people aged 60 to 79 and those at risk of severe disease
-
Annual report 2021
Annual report 2021
-
Annual report 2021
Annual report 2021
EMA has published its 2021 annual report that provides an overview of the Agency’s major achievements, key figures and contributions to public and animal health in Europe
Information for you
Key content
Services & databases
-
List item
Clinical Trials website
-
List item
Account Management portal
-
List item
eSubmission
-
List item
EudraVigilance (human)
-
List item
EudraVigilance Veterinary
-
List item
Veterinary Medicines information website
-
List item
Suspected adverse drug reactions database
-
List item
Clinical data
-
List item
SPOR data management services
-
List item
Service Desk
-
List item
IRIS platform
-
List item
Public register of parallel distribution notices
-
List item
European Vaccination Information Portal